Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 2, 2002, Pages 316-327

  Martinez, Alvaro A ^a   Gustafson, Gary ^a   Gonzalez, José ^a   Armour, Elwood ^a   Mitchell, Chris ^a   Edmundson, Gregory ^a   Spencer, William ^a   Stromberg, Jannifer ^a   Huang, Raywin ^a   Vicini, Frank ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Conformal radiotherapy; High dose rate brachytherapy; Outcome; Prostate cancer

Indexed keywords

ANTIGENS; DISEASES; DRUG DOSAGE; HORMONES; IRRADIATION; PATIENT TREATMENT; TUMORS; ULTRASONIC APPLICATIONS;

MULTIVARIATE ANALYSES;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; RATING SCALE; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 0036603734     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02733-5     Document Type: Article

References (49)

1. Status of radiation treatment of prostate cancer at Stanford University
2. Tumor control in definitive irradiation of localized carcinoma of the prostate
3. A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States
4. Stage C adenocarcinoma of the prostate: An analysis of 551 patients treated with external beam irradiation
5. Radiotherapy for prostatic carcinoma: Post-irradiation prostatic biopsy and recurrence patterns with long-term followup
6. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma: Stage III, predict long-term survival?
7. The effect of local control on metastatic dissemination in carcinoma of the prostate: Long term results in patients treated with I-125 implantation
8. Prostate
9. Androgen deprivation with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group
10. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
11. Beneficial effect of combination hormonal therapy administered prior and following external beam irradiation in localized prostate cancer
12. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
13. The experience with neutron irradiation in locally advanced adenocarcinoma of the prostate
14. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma
15. Pd 103 brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma
16. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
17. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy
18. Conformal prostate brachytherapy: Initial experience of a phase I/II clinical trial
19. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial
20. Analysis of prostate and seminal vesicle motion: Implications for treatment planning
21. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning
22. The use of adaptive radiation therapy to reduce setup error: A prospective clinical study
23. Managing geometric uncertainty in conformal intensity-modulated radiation therapy
24. Adaptive radiation therapy
25. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors
26. Improvement in dose escalation using the process of adaptive radiotherapy combined with 3D-conformal or intensity modulated beams for prostate cancer
27. Geometry based optimization for stepping source implants
28. Concurrent treatment planning for outpatient high dose rate prostate template implants
29. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy
30. Overcoming internal prostate motion and set-up inaccuracies with conformal interstitial brachytherapy
31. Interim report of image-guided conformal high-dose rate brachytherapy for patients with unfavorable prostate cancer: The William Beaumont Phase II dose-escalating trial
32. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: Superior prostate-specific antigen response compared with external beam treatment
33. Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer
34. Review: Total doses in fractionated radiotherapy - Implications of new radiobiological data
35. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses
36. Fractionation and protraction of radiotherapy of prostate carcinoma
37. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high dose rate brachytherapy
38. Direct evidence that prostate tumors show high sensitivity to fraction (low α/β ratio), comparable to late-responding normal tissue
39. Prostate adenocarcinoma volume and radiation dose are the primary factors in the dose-response relationship of unfavorable prostate adenocarcinoma
40. Consensus statement. Guidelines for PSA following radiation therapy
41. Nonparametric estimation from incomplete observations
42. Evaluation of survival data and two new rank order statistics arising in its consideration
43. Regression m models and life-tables
44. Combined treatment with temporary short term high dose rate Ir-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma
45. High dose rate interstitial with external beam irradiation for localized prostate cancer - Results of a prospective trial
46. Prostate preservation by combined external beam and HDR brachytherapy at node negative prostate cancer patients: An intermediate analysis after 10 years experience
47. High dose-rate afterloading iridium-192 prostate brachytherapy: Feasibility report
48. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report